Introduction
The University of Iowa Public Policy Center (UI PPC) is conducting an evaluation of the Iowa State Innovation Model (SIM) for the Iowa Medicaid Enterprise (IME). This report presents the results of two portions of the evaluation: 1) baseline outcomes regarding emergency department (ED) visits, plan all cause admissions and total cost of care, and 2) an assessment of the status of the acquisition of data that is required for many other portions of the evaluation. These two items were important activities for the first two years of the evaluation of Iowa's SIM.
Background
The State Innovation Model grant has three primary aims.
1) Improve population health
2) Transform health care
3) Promote sustainability
For more information about these aims and their related goals please go to the SIM home page http:// dhs.iowa.gov/ime/about/initiatives/newSIMhome .
In response to these aims and goals, the state-led evaluation team at the UI PPC, in conjunction with the Iowa Department of Human Services (IDHS), Iowa Department of Public Health (IDPH), and the Centers for Medicare and Medicaid Innovation (CMMI), developed hypotheses and outcome measures to evaluate the success of Iowa's SIM. Table 1 lists these hypotheses, measures, data sources and outcome target dates as provided in the state-led evaluation plan. People with diabetes will experience improved quality of life (QoL) . The rate of tobacco use will decrease by 1% over the 3 years of the SIM .
Rate of reported tobacco use BRFSS/YRBS 6/30/2017 and 6/30/2018
The rate of elective C-sections and early elective deliveries will be reduced . The proportion of Medicaid primary care providers in value-based purchasing contracts will increase to 70% by the third year .
Proportion of Medicaid Primary care providers in VBP contracts
Medicaid provider dataset 12/31/2018
Baseline outcome measures
The PPC calculated three baseline outcome measures for later comparison for the SIM evaluation: ED Visits, Plan All-Cause Readmissions, and Total Cost of Care. The baseline measures were calculated using only Medicaid administrative data at this time. Wellmark and Medicare data were not yet available. Medicaid populations included in these analyses were those in the FMAP, CMAP and SSI programs.
ED visits
Baseline ED visit rate for the Iowa Medicaid population were calculated according to CMS specifications for adult core measures. Rates are reported as unadjusted visits per 1,000 months of eligibility in CY 2015 (Figure 1 ). Overall there were 62 ED visits per 1,000 months of eligibility. Infants under age one and adults ages 20-44 were the most likely to have an ED visit during CY 2015.
Plan all-cause readmissions
Plan all-cause readmissions reflect hospital admissions that occur within the first 30 days following a discharge. The plan all-cause readmissions rates are not risk adjusted. Table 2 shows the unadjusted plan all-cause readmissions in CY 2015 for the for the Iowa Medicaid population. There was a total of 17,026 inpatient stays for Medicaid enrollees in CY 2015. For almost 2,000 of these visits (1,946) there was a readmission to the hospital within 30 days (11.4%). Adults ages 45-54 were most likely to have a readmission, however there was not wide variation by age.
Total cost of care
Total cost of care was calculated using the Health Partners analytic package with Adjusted Clinical Groups (ACGs) to provide the risk adjustment for Medicaid enrollees in CY 2015. The average risk-adjusted per member/per month cost for Medicaid members in CY 2015 was $362.46. The largest portion of this cost ($275) was attributable to medical care (e.g., physician services).
Data acquisition
Completion of many of the outcome measures for the SIM evaluation require an extensive set of databases and data collection tools. Table 4 lists the databases and data collection tools that would be needed to complete the evaluation plan as originally outlined and the progress that has been made to acquire and assimilate these data. There have been significant challenges encountered trying to obtain many of these datasets.
Challenges have included issues such as getting proper approvals to the timing of the data collection for the information in these datasets not matching the needs of the evaluation. As indicated in the table however, all of these datasets will continue to be pursued with acquisition anticipated to occur in 2017.
